GAITHERSBURG, Md.–(BUSINESS WIRE)–Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced the appointment of Evan Loh, M.D., CEO of Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), Jonathan Leff, Partner at Deerfield Management, and Jana Jensen, Ph.D., Chief Operating Officer at Deerfield Discovery and Development, to the company’s Board of Directors.
{iframe}https://www.businesswire.com/news/home/20210629005154/en/Adaptive-Phage-Therapeutics-Expands-Board-Following-Series-B-Financing-Led-by-Deerfield-Management#.YNsfMFpFiXY.linkedin{/iframe}